About 1 result found for searched term "Etrolizumab" (0.132 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M24543 | Etrolizumab | Integrin |
| rhuMAb Beta7; RG7413; PRO145223 | ||
| Etrolizumab (rhuMAb Beta7) is a gut-selective, anti-β7 integrin monoclonal antibody. Etrolizumab is specific targeting of the β7 subunit of α4β7 and αEβ7 integrins with Ki values of 18 nM and 1800 pM for Human α4β7 and Human αEβ7-293, respectively. Etrolizumab can be used in research of inflammatory bowel disease (IBD). | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
